Description
This compound is a derivative of methyl caffeate, a hydroxycinnamic acid; it exhibits chemopreventive potential, inhibiting the development of colon tumors in vivo.
| Product Unit Size | Cost | Quantity | Stock |
|---|
This compound is a derivative of methyl caffeate, a hydroxycinnamic acid; it exhibits chemopreventive potential, inhibiting the development of colon tumors in vivo.
| Purity | ≥98% |
|---|---|
| Formula | C18H18O4 |
| Formula Wt. | 298.33 |
| IUPAC Name | 2-phenylethyl 3-(3-hydroxy-4-methoxyphenyl)propanoate |
| Appearance | White Crystal Powder |
| Store Temp | 4°C |
|---|---|
| Ship Temp | Ambient |
| MSDS | |
|---|---|
| Info Sheet |
Pereira MA. Prevention of colon cancer and modulation of aberrant crypt foci, cell proliferation, and apoptosis by retinoids and NSAIDs. Adv Exp Med Biol. 1999;470:55-63. PMID: 10709674.
Saturated cyclic acid used to store phosphorus ...
SRPK1 inhibitor.
Curcumin derivative.
Fluoroquinolone; topoisomerase IV and bacterial...
Prodrug
M3 mAChR antagonist.
Aminoglycoside; protein translation inhibitor, ...
Topoisomerase II inhibitor, RPA modulator.
Synthetic cafestol derivative.
FAAH inhibitor.
Melatonin analog; MT1/2 agonist.
β2-adrenergic agonist.
PIKfyve inhibitor.
Wnt signaling inhibitor.
Neuropeptide found in insects.
Toxin found in Aconitum; voltage-gated Na+ chan...
Organosulfur found in garlic.
IMPDH inhibitor.
1,8-Diaza-anthracene-tetrone; JNK and ERK5 inhi...
Polyphenol found in Camilla sinensis; HIV integ...